Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
International Survey of Clinical Monitoring Practices in Pancreas and Islet Transplantation.
Ward C, Odorico JS, Rickels MR, Berney T, Burke GW 3rd, Kay TWH, Thaunat O, Uva PD, de Koning EJP, Arbogast H, Scholz H, Cattral MS, Stratta RJ, Stock PG; for the International Pancreas and Islet Transplant Association Beta-Cell Replacement Therapy Monitoring Task Force. Ward C, et al. Among authors: de koning ejp. Transplantation. 2022 Aug 1;106(8):1647-1655. doi: 10.1097/TP.0000000000004058. Epub 2022 Jul 22. Transplantation. 2022. PMID: 35019897 Free PMC article.
Microvascular damage in type 1 diabetic patients is reversed in the first year after simultaneous pancreas-kidney transplantation.
Khairoun M, de Koning EJ, van den Berg BM, Lievers E, de Boer HC, Schaapherder AF, Mallat MJ, Rotmans JI, van der Boog PJ, van Zonneveld AJ, de Fijter JW, Rabelink TJ, Reinders ME. Khairoun M, et al. Am J Transplant. 2013 May;13(5):1272-81. doi: 10.1111/ajt.12182. Epub 2013 Feb 22. Am J Transplant. 2013. PMID: 23433125 Free article.
Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas-kidney transplantation.
Bijkerk R, Duijs JM, Khairoun M, Ter Horst CJ, van der Pol P, Mallat MJ, Rotmans JI, de Vries AP, de Koning EJ, de Fijter JW, Rabelink TJ, van Zonneveld AJ, Reinders ME. Bijkerk R, et al. Am J Transplant. 2015 Apr;15(4):1081-90. doi: 10.1111/ajt.13072. Epub 2015 Feb 25. Am J Transplant. 2015. PMID: 25716422 Free article.
Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression.
Nijhoff MF, Engelse MA, Dubbeld J, Braat AE, Ringers J, Roelen DL, van Erkel AR, Spijker HS, Bouwsma H, van der Boog PJ, de Fijter JW, Rabelink TJ, de Koning EJ. Nijhoff MF, et al. Am J Transplant. 2016 Jan;16(1):246-53. doi: 10.1111/ajt.13425. Epub 2015 Aug 19. Am J Transplant. 2016. PMID: 26288226 Free article.
Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop.
Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R, Bellin MD, Berney T, Choudhary P, Johnson PR, Kandaswamy R, Kay TWH, Keymeulen B, Kudva YC, Latres E, Langer RM, Lehmann R, Ludwig B, Markmann JF, Marinac M, Odorico JS, Pattou F, Senior PA, Shaw JAM, Vantyghem MC, White S. Rickels MR, et al. Among authors: de koning ejp. Transpl Int. 2018 Apr;31(4):343-352. doi: 10.1111/tri.13138. Transpl Int. 2018. PMID: 29453879 Free PMC article. Review.
Defining outcomes for beta cell replacement therapy: a work in progress.
Piemonti L, de Koning EJP, Berney T, Odorico JS, Markmann JF, Stock PG, Rickels MR. Piemonti L, et al. Among authors: de koning ejp. Diabetologia. 2018 Jun;61(6):1273-1276. doi: 10.1007/s00125-018-4588-0. Epub 2018 Mar 6. Diabetologia. 2018. PMID: 29511779 Free PMC article.
198 results